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INTRODUCTION
Mycobacterium avium-intracellulare complex (MAC) is ubiquitous in the environment and it has been thought to be an opportunistic pathogen i.e., to show pathogenicity in immunocompromised hosts or persons with preexisting pulmonary diseases such as chronic obstructive pulmonary disease (COPD). Accordingly, the MAC infectious disease is found in a high percentage of patients [1] However, MAC has been recognized [2-5] to cause pulmonary disease in immunocompetent persons without preexisting pulmonary disease, i.e., to cause primary pulmonary MAC disease. The prognosis of primary pulmonary MAC disease is poor, because this is a chronic, slowly progressing, disease and because few anti-microbial agents against MAC are available. There are two forms of primary pulmonary MAC disease, distinguished on the basis of the chest radiographic features. One form, tuberculosis-like (TB) form, resembles pulmonary tuberculosis, while the other form, nodular-bronchiectasis (NB) form, is associated with mid-lung infiltrate and bronchiectasis in older females. The TB form progresses about twice as fast as the NB form. The immunological mechanism underlying the primary pulmonary MAC disease has not been well clarified, but it seems to be different from that underlying the MAC infectious disease in the patients with HIV infectious disease.
This study was done to clarify the immunological features of the patients with primary pulmonary MAC disease by comparing the cytokine-producing ability of peripheral blood mononuclear cells The control healthy volunteers agreed to join this study and showed no abnormality upon blood laboratory examination and chest X-ray examination (Table 1) .
Clinical laboratory
The patients were examined by the clinical laboratory examination (Table 2 ). In addition, three respiratory medical specialists reviewed all the chest Xray and thorax computed tomography data of each patient, and classified the patients into NB form and TB form and evaluated the present state of disease activity. The disease was presumed to be active when the patient's chest radiography showed deterioration of the lung at least once within the past one year or MAC was cultured from the sputum within the past 6 months.
Assay of cytokine production by PBMC after stimulation with purified protein derivative-B (PPD-B) in vitro Concentration of cytokines in the culture supernatants was measured by enzyme linked immunosorbent assay (ELISA). ELISA kits were used to measure concentrations of IFN-y, IL-10 (Immunotech) and TNF-a (BML). The concentration of IFN-y was expressed as the value per 1 X106 lymphocytes in culture fluids and those of IL-10 and TNF-a were expressed as the value per 1 X 106 mononuclear cells in culture fluids. 
RESULTS
Characteristics of the patients and healthy volunteers are shown on Table 1 . In addition to the classification into NB or TB form,based on the chest Xray picture, the patients were classified into three groups on the basis of the clinical findings. The deterioration (-)/culture (-) (group I) was a group of patients whose disease state inactive and stable. The deterioration (+)/culture (-) (group II) was a group of patients are whose disease state was unstable and active, but at a lower level than the next group. The deterioration (+)/culture (+) (group i) was a group of patients whose disease state was the most active of the three groups. We excluded some patients who had MAC within their sputum but showed no deterioration on chest radiography because such cases were few.
The laboratory results of these three groups are shown in Table 2 . Groups II and III showed significantly higher ESR, WBC and CRP values than group I. Regarding serum albumin and body weight, group III showed significantly lower values, than groups I and II. The concentrations of IFN-y, IL-10 &nd TNFa in the culture supernatants of each test tube were significantly higher than in the matched control tube (data not shown). This means that the PBMC of all patients and healthy subjects reacted with the MAC antigen, PPD-B. Therefore we compared the production of cytokines by PBMC in response to stimulation with PPD-B between the patient and the healthy control groups. IFN-y in each of the three patient groups was lower than in the healthy control group. There was no significant difference in the concentration of IFN-y among the three patient groups. The three patient groups showed a tendency to produce higher amounts of IL-10 than the healthy control group; in particular group II and III showed significantly higher levels of IL-10 than the healthy control group; in particular. Group II and IQ showed significantly higher levels of IL-10 than the control group (Table 3) . TNF-a was significantly lower in group I patients than in the healthy control group. TNF-a of groups II and III was significantly higher than the in group I, and group III showed the highest TNF-a level among them (Table 4) . The patients were classified by clinical form into 35 NB forms and 11 TB forms. Because there were few patients with TB form belonging to group I or II (table 1), the comparison between TB form and NB form was done for group III only. No significant difference in the production of IFN-y, IL-10 and TNFa was found between them (Table 5 and 6).
DISCUSSION
The host defense mechanisms against MAC, a facultative intracellular pathogen, resemble those against Mycobacterium tuberculosis, whereby cellmediated immunity is important [9-11]. After the initial infection, the host macrophages phagocytose MAC and process it. Then they transfer the information of MAC antigen to T lymphocytes and produce IL-12. IL-12 is thought as an essential cytokine that differentiates naive helper T cells (Th0) 
